SoylentNews is people
SoylentNews
from the goal:-to-help-people-or-to-make-money? dept.
Samsung Biologics Co., the contract drug making unit of Samsung Group, made its market debut in Seoul on Thursday in South Korea's largest initial public offering in six years.
Samsung is looking to biotech to be a new core business on a par with its semiconductor manufacturing. The company has included bio-tech and health care in the five businesses it named as future growth engines for the next decade, to counter slowing growth in its key consumer electronics businesses.
Just as it has made huge profits suppling microchips to Apple and other tech companies, Samsung believes it can supply biologic drugs to global pharmaceutical companies.
There is also a leadership transition at play.
Growing Samsung Biologics will test the mettle of Lee Jae-yong, the 48-year-old Samsung heir, who is poised to take over leadership of South Korea's largest business group. There's a precedent: In the 1980s, Samsung Electronics' venture into the memory chip business helped establish Lee's father Lee Kun-hee, now 74 and ailing, as Samsung's chairman.
(Score: 2) by Snotnose on Saturday November 12 2016, @04:49AM
Zombies kill off the slow moving and the stupid; eg the old, the infirm, the too drunk to run crowd, the "lets stand here in the middle of nowhere with zillions of zombies and we have masonry trowels". Zombies fill a positive ecological niche, if they catch you we're better off without you.
When the dust settled America realized it was saved by a porn star.
(Score: 0) by Anonymous Coward on Saturday November 12 2016, @05:13AM
Unless they are from the "fast zombies" style (I am legend, World War Z, Resident Evil and such... OK, Legend one is vampires, but still), then everyone is fucked.